Literature DB >> 23079532

Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Jay H Fowke1, Saundra Motley, Qi Dai, Raoul Concepcion, Daniel A Barocas.   

Abstract

Prostate enlargement is common with aging and obesity. We investigated the association between obesity and prostate cancer controlling for differential detection related to prostate enlargement. In an analysis of 500 men, we found body mass index, waist-hip ratio, and blood leptin levels were significantly associated with high-grade PC, but only among men without prostate enlargement. Leptin was also significantly associated with high-grade prostatic intraepithelial neoplasia (HGPIN) in the absence of prostate enlargement. Our results suggest obesity advances prostate carcinogenesis, and that detection biases at prostate biopsy may explain past inconsistencies in the association between obesity and PC.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079532      PMCID: PMC3513505          DOI: 10.1016/j.canlet.2012.10.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  52 in total

Review 1.  Energetics in colorectal and prostate cancer.

Authors:  Jeffrey A Meyerhardt; Jing Ma; Kerry S Courneya
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Obesity and prostate cancer screening among African-American and Caucasian men.

Authors:  Jay H Fowke; Lisa B Signorello; Willie Underwood; Flora A M Ukoli; William J Blot
Journal:  Prostate       Date:  2006-09-15       Impact factor: 4.104

3.  Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.

Authors:  James P Burke; Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Rosebud O Roberts; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2006-04-12       Impact factor: 4.897

4.  The association between body size, prostate volume and prostate-specific antigen.

Authors:  J H Fowke; S S Motley; M S Cookson; R Concepcion; S S Chang; M L Wills; J A Smith
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-12-19       Impact factor: 5.554

5.  Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.

Authors:  Jay H Fowke; Saundra S Motley; Marcia Wills; Michael S Cookson; Raoul S Concepcion; Charles W Eckstein; Sam S Chang; Joseph A Smith
Journal:  Cancer Causes Control       Date:  2007-03-01       Impact factor: 2.506

6.  Weight change and prostate cancer incidence and mortality.

Authors:  Julie K Bassett; Gianluca Severi; Laura Baglietto; Robert J MacInnis; Hoa N Hoang; John L Hopper; Dallas R English; Graham G Giles
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

7.  Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

Authors:  J A Johnson; S L Bowker; K Richardson; C A Marra
Journal:  Diabetologia       Date:  2011-07-12       Impact factor: 10.122

8.  Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Authors:  William W Bassett; Matthew R Cooperberg; Natalia Sadetsky; Stefanie Silva; Janeen DuChane; David J Pasta; June M Chan; Jason W Anast; Peter R Carroll; Christopher J Kane
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

9.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

10.  Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.

Authors:  R S Price; D A Cavazos; R E De Angel; S D Hursting; L A deGraffenried
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-02-14       Impact factor: 5.554

View more
  12 in total

1.  Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.

Authors:  Andrew Rundle; Yun Wang; Sudha Sadasivan; Dhananjay A Chitale; Nilesh S Gupta; Deliang Tang; Benjamin A Rybicki
Journal:  Prostate       Date:  2017-03-27       Impact factor: 4.104

2.  Pleiotropy between genetic markers of obesity and risk of prostate cancer.

Authors:  Todd L Edwards; Ayush Giri; Saundra Motley; Wynne Duong; Jay H Fowke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-06-27       Impact factor: 4.254

3.  Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer.

Authors:  Jay H Fowke; Saundra S Motley
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

4.  Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.

Authors:  Gabriel Y Lai; Edward L Giovannucci; Michael N Pollak; Sarah B Peskoe; Meir J Stampfer; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-03-25       Impact factor: 2.506

Review 5.  Skeletal Muscle-Adipose Tissue-Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer.

Authors:  Sílvia Rocha-Rodrigues; Andreia Matos; José Afonso; Miguel Mendes-Ferreira; Eduardo Abade; Eduardo Teixeira; Bruno Silva; Eugenia Murawska-Ciałowicz; Maria José Oliveira; Ricardo Ribeiro
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

6.  The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro.

Authors:  Benjamin C Mora; Neil E Fleshner; Laurence H Klotz; Vasundara Venkateswaran
Journal:  Lipid Insights       Date:  2015-04-19

7.  Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.

Authors:  Nagi B Kumar; Roshni Patel; Julio Pow-Sang; Philippe E Spiess; Raoul Salup; Christopher R Williams; Michael J Schell
Journal:  Oncotarget       Date:  2017-06-29

8.  Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort.

Authors:  Bo Tang; Cheng-Tao Han; Gui-Ming Zhang; Cui-Zhu Zhang; Wei-Yi Yang; Ying Shen; Adriana C Vidal; Stephen J Freedland; Yao Zhu; Ding-Wei Ye
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

9.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.

Authors:  Neil M Davies; Tom R Gaunt; Sarah J Lewis; Jeff Holly; Jenny L Donovan; Freddie C Hamdy; John P Kemp; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Fredrik Wiklund; Henrik Gronberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; David Neal; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Hardev Pandha; Mark Lathrop; George Davey Smith; Richard M Martin
Journal:  Cancer Causes Control       Date:  2015-09-19       Impact factor: 2.506

10.  Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.

Authors:  Antonio Cicione; Cosimo De Nunzio; Andrea Tubaro; Francesco Cantiello; Stefano Manno; Carlos Oliveira; Estevao Lima; Rocco Damiano
Journal:  BMC Cancer       Date:  2016-02-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.